N-terminal pro-brain natriuretic peptide in arterial hypertension: A valuable prognostic marker of cardiovascular events

被引:29
作者
Pedersen, F [1 ]
Raymond, I [1 ]
Kistorp, C [1 ]
Sandgaard, N [1 ]
Jacobsen, P [1 ]
Hildebrandt, P [1 ]
机构
[1] Copenhagen Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark
关键词
hypertension; natriuretic peptides; prognosis; cardiovascular risk;
D O I
10.1016/j.cardfail.2005.04.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: N-terminal pro-brain natriuretic peptide (NT-proBNP) provides important prognostic information in patients with chronic heart failure and in the general population. The aim of this study was to evaluate NT-proBNP as a prognostic marker of cardiovascular morbidity and death in a sample of subjects with hypertension and preserved left ventricular systolic function from the general population. Methods and Results: The study population was recruited from 4 general practitioners. The study participants (n = 569 subjects; ages, 50-89 years) completed a heart failure questionnaire and were submitted to blood pressure measurement, electrocardiography, echocardiography, and blood sampling. After exclusion of subjects with left ventricular ejection fraction of < 50%, 270 subjects fulfilled the following criteria for hypertension: history of hypertension or blood pressure > 150/90 mm Hg. During 3 years of follow-up, 28 subjects (10.4%) reached the composite end point of death, stroke/transient ischemic attack, or myocardial infarction. After adjustment for cardiovascular risk factors, NT-proBNP (logarithmically transformed) independently predicted the risk of experiencing a composite end point (hazard ratio, 1.94; P < .0001), and death (hazard ratio, 2.28; P < .0001). The risk of having a composite end point (21 vs 7; P = .005) was significantly higher for subjects with NT-proBNP above the study median than for subjects with NT-proBNP below the study median. Conclusion: In this sample of subjects with hypertension and preserved left ventricular systolic function from the general population, plasma NT-proBNP was found to be a valuable cardiovascular risk marker, independently of traditional risk factors and prevalent cardiovascular disease.
引用
收藏
页码:S70 / S75
页数:6
相关论文
共 23 条
[21]   Plasma natriuretic peptide levels and the risk of cardiovascular events and death [J].
Wang, TJ ;
Larson, MG ;
Levy, D ;
Benjamin, EJ ;
Leip, EP ;
Omland, T ;
Wolf, PA ;
Vasan, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :655-663
[22]   Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy [J].
Yamamoto, K ;
Burnett, JC ;
Jougasaki, M ;
Nishimura, RA ;
Bailey, KR ;
Saito, Y ;
Nakao, K ;
Redfield, MM .
HYPERTENSION, 1996, 28 (06) :988-994
[23]   DIFFERENT SECRETION PATTERNS OF ATRIAL-NATRIURETIC-PEPTIDE AND BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
YOSHIMURA, M ;
YASUE, H ;
OKUMURA, K ;
OGAWA, H ;
JOUGASAKI, M ;
MUKOYAMA, M ;
NAKAO, K ;
IMURA, H .
CIRCULATION, 1993, 87 (02) :464-469